Additional Coverage:
A generic version of the popular allergy medication Zyrtec is being recalled nationwide due to possible contamination with a heartburn drug, the Food and Drug Administration announced.
Unique Pharmaceutical Laboratories is voluntarily recalling its cetirizine hydrochloride tablets USP 5 mg, a common antihistamine used to relieve seasonal allergy symptoms. The recall was initiated on July 18 after a pharmacy technician noticed unusual discoloration-specifically a red dot and other color changes-on some of the tablets during packaging.
The concern arises from potential cross-contamination with ranitidine, a medication used to treat heartburn. The FDA warns that individuals who are allergic or sensitive to ranitidine may experience serious side effects if exposed, including low blood pressure, difficulty breathing or swallowing, loss of consciousness, and other severe reactions.
So far, no adverse events linked to the recalled products have been reported. The recall covers specific product codes: GY825029, GY825030, GY825031, and GY825032.
Rising Pharmaceutical Holdings, which distributes the medication, has informed customers about the recall and is coordinating the return of affected products.
Consumers with questions can contact Rising Pharmaceutical Holdings at 1-844-874-7464 or via email at [email protected] or [email protected]. Patients experiencing any symptoms or concerns related to the medication are advised to consult their healthcare provider promptly.